CryoPort, Inc. CYRX

Company Overview

Cryoport, Inc. (NASDAQ: CYRX) is a global supply chain and logistics company focused on temperature-controlled solutions for the life sciences industry. The company primarily supports the biopharmaceutical, cell and gene therapy, reproductive medicine, and animal health sectors by providing specialized cryogenic logistics, biostorage, and supply chain management services. Cryoport’s core business model centers on enabling the transport, storage, and monitoring of biologic materials that require highly controlled thermal environments, particularly for advanced therapies such as CAR-T cell therapies and regenerative medicine products.

The company evolved from a cryogenic logistics provider into an integrated life sciences supply chain platform through a series of acquisitions and strategic expansions. Its growth has been driven by increasing demand for cell and gene therapy commercialization infrastructure, as well as the rising complexity of biologic drug distribution. Cryoport positions itself as an end-to-end partner for pharmaceutical and biotechnology companies by combining logistics, biostorage, analytics, and specialized handling capabilities under a unified platform.